Notice
2 Jul 2025
grants, health, research, biotechnology, patent licensing, immune response
🦠Exclusive License Opportunity for Engineered Commensal Bacteria Technology
The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive, Inter- Institutional Agreement-Institution Lead to CZ Biohub SF, LLC ("CZB"), located in San Francisco, California, in its rights to the technologies and patent applications listed in the Supplementary Information section of this notice.
Learn More